首页> 外国专利> METHOD FOR PREPARING HIGHLY PURIFIED PREPARATION OF CERULOPLASMIN FERROXIDASE AND/OR BLOOD COAGULATION FACTOR PROTHROMBIN, AFFINE NEOMYCINE SORBENT FOR PREPARING THEM

METHOD FOR PREPARING HIGHLY PURIFIED PREPARATION OF CERULOPLASMIN FERROXIDASE AND/OR BLOOD COAGULATION FACTOR PROTHROMBIN, AFFINE NEOMYCINE SORBENT FOR PREPARING THEM

机译:纯化血浆铜铁蛋白铁氧合酶和/或凝血因子凝血酶原的制备方法,仿射神经氨酸吸附剂的制备方法

摘要

FIELD: medicine, pharmaceutics.;SUBSTANCE: substance of the invention is a method for recovering the preparations of ceruloplasmin (CP) and prothrombin (FIT) of human and mammalian blood plasma by two sequential chromatographies on anion sorbents, UNOQ-Sphere and neomycine agarose. UNOQ-Sphere contains -(+)N(CH3)3 - groups, and the affine sorbent contains neomycine agarose synthetised by the authors on the basis of the antibiotic neomycine a molecule of which contains 6NH2-groups. The prepared highly purified preparation of CP contains no FII and active thrombin (Flla), main proteinase causing proteoclastic degradation of CP. The preparation of CP contains up to 90% of non-degraded 132-kDa protein, characterised by a high criterion of purity A610/A280 - 0.052 and contains 5.9±0.1 mole of copper per a mole of CP. The above preparation of CP is stable for 2 months if stored aseptically even at 37°C. Preparing the pure end product CP of neomycine agarose is accompanied by recovering FII to be used as a raw material for preparing the haemostatic Flla.;EFFECT: advantage of the declared method represents no need for dissolving initial plasma at the first stage of the recovery, a short overall length of the recovery being 1-2 days, and a possibility to using the preparation in practice for scientific application and pharmaceutical industry.;2 cl, 4 dwg, 3 tbl, 6 ex
机译:领域:本发明的物质是通过阴离子吸附剂UNOQ-Sphere和新霉素琼脂糖上的两种连续色谱法回收人和哺乳动物血浆中的铜蓝蛋白(CP)和凝血酶原(FIT)制剂的方法。 UNOQ-Sphere包含-(+)N(CH 3 3 -基团,仿射吸附剂包含作者根据抗生素新霉素a合成的新霉素琼脂糖。其分子含有6NH 2 -基团。制备的高纯度CP制剂不含FII和活性凝血酶(Fla),后者是引起CP破蛋白降解的主要蛋白酶。 CP的制备包含高达90%的未降解的132-kDa蛋白,其高纯度标准为A 610 / A 280 -0.052,且含量为5.9±每摩尔CP 0.1摩尔铜。如果即使在37°C下无菌保存,上述CP制剂也可以稳定保存2个月。制备新霉素琼脂糖的纯净最终产物CP的过程中要回收FII,以用作制备止血Flla的原料。效果:所声明方法的优势在于无需在回收的第一阶段溶解初始血浆,回收期较短,为1-2天,并且有可能在科学应用和制药行业中实际使用该制剂。; 2 cl,4 dwg,3 tbl,6 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号